Literature DB >> 22338601

Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis.

Monique Hinchcliff1, Chintan S Desai, John Varga, Sanjiv J Shah.   

Abstract

OBJECTIVES: To determine the frequency, associated clinical factors, and prognostic significance of left ventricular (LV) diastolic dysfunction in systemic sclerosis (SSc).
METHODS: We studied 153 consecutive patients with SSc and divided the study sample into those with and without LV diastolic dysfunction using established age-based normal cut-offs for lateral tissue Doppler early mitral annular (E') velocity, a marker of impaired relaxation and diastolic dysfunction. We compared clinical characteristics, laboratory tests, pulmonary function tests, and echocardiographic data between those with and without LV diastolic dysfunction. We used multivariable linear regression analyses to determine the factors most associated with lateral tissue Doppler E' velocity. We also performed multivariable Cox regression analyses to determine whether or not tissue Doppler E' velocity was independently associated with mortality.
RESULTS: LV diastolic dysfunction was present in 23% of the subjects, whereas LV systolic dysfunction was present in 5.2% of subjects. Factors independently associated with LV diastolic dysfunction on multivariable analysis included SSc disease duration, age, coronary artery disease, and systemic hypertension. During a mean follow-up of 1.9±1.3 years, LV diastolic dysfunction was independently associated with increased risk of death (hazard ratio [HR] 3.2, 95% confidence interval [CI] 1.1-9.5, p=0.034 per each standard deviation decrease in tissue Doppler E' velocity).
CONCLUSIONS: LV diastolic dysfunction in SSc is independently associated with disease duration and is a marker of increased risk of death.

Entities:  

Mesh:

Year:  2012        PMID: 22338601      PMCID: PMC3507505     

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  34 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

3.  Left ventricular function in scleroderma.

Authors:  G P Armstrong; G A Whalley; R N Doughty; G D Gamble; S M Flett; P L Tan; D N Sharpe
Journal:  Br J Rheumatol       Date:  1996-10

Review 4.  Cardiac involvement in scleroderma.

Authors:  A Deswal; W P Follansbee
Journal:  Rheum Dis Clin North Am       Date:  1996-11       Impact factor: 2.670

5.  Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve.

Authors:  G Valentini; D F Vitale; A Giunta; S Maione; G Gerundo; M Arnese; E Tirri; N Pelaggi; A Giacummo; G Tirri; M Condorelli
Journal:  Ann Rheum Dis       Date:  1996-07       Impact factor: 19.103

6.  Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients.

Authors:  T A Medsger; A T Masi
Journal:  J Chronic Dis       Date:  1973-10

7.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

9.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

Review 10.  The heart in systemic sclerosis.

Authors:  Virginia Steen
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

View more
  31 in total

Review 1.  Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries.

Authors:  Michele Iudici; Serena Fasano; Daniela Iacono; Barbara Russo; Giovanna Cuomo; Gabriele Valentini
Journal:  Clin Rheumatol       Date:  2013-11-19       Impact factor: 2.980

2.  Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort.

Authors:  Matthew R Lammi; Lesley A Saketkoo; Jessica K Gordon; Paula Lauto; Karen Fagan; Virginia D Steen
Journal:  Respirology       Date:  2017-05-12       Impact factor: 6.424

3.  Evaluation of left and right ventricle by two-dimensional speckle tracking echocardiography in systemic sclerosis patients without overt cardiac disease.

Authors:  Duygu Temiz Karadag; Tayfun Sahin; Senem Tekeoglu; Ozlem Ozdemir Işik; Ayten Yazici; Fatma Ceyla Eraldemir; Ayse Cefle
Journal:  Clin Rheumatol       Date:  2019-05-24       Impact factor: 2.980

Review 4.  Echocardiography in the Assessment of Patients with Rheumatologic Diseases.

Authors:  Maha A Al-Mohaissen; Kwan-Leung Chan
Journal:  Curr Cardiol Rep       Date:  2016-08       Impact factor: 2.931

Review 5.  Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis.

Authors:  George Hung; Valentina Mercurio; Steven Hsu; Stephen C Mathai; Ami A Shah; Monica Mukherjee
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

6.  Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance.

Authors:  Christian Cadeddu; Martino Deidda; Giuseppina Giau; Marzia Lilliu; Fabio Cadeddu; Giulio Binaghi; Mario Nicola Mura; Michela Farci; Stefano Del Giacco; Paolo Emilio Manconi; Giuseppe Mercuro
Journal:  Int J Cardiovasc Imaging       Date:  2014-12-30       Impact factor: 2.357

Review 7.  Determinants of mortality in systemic sclerosis: a focused review.

Authors:  Dilli Ram Poudel; Divya Jayakumar; Abhijeet Danve; Shiv Tej Sehra; Chris T Derk
Journal:  Rheumatol Int       Date:  2017-11-07       Impact factor: 2.631

8.  2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension.

Authors:  Chih-Hsin Hsu; Wan-Jing Ho; Wei-Chun Huang; Yu-Wei Chiu; Tsu-Shiu Hsu; Ping-Hung Kuo; Hsao-Hsun Hsu; Jia-Kan Chang; Chin-Chang Cheng; Chao-Lun Lai; Kae-Woei Liang; Shoa-Lin Lin; Hsao-Hsun Sung; Wei-Chuan Tsai; Ken-Pen Weng; Kai-Sheng Hsieh; Wei-Hsian Yin; Shing-Jong Lin; Kuo-Yang Wang
Journal:  Acta Cardiol Sin       Date:  2014-09       Impact factor: 2.672

9.  Diffuse cardiac fibrosis quantification in early systemic sclerosis by magnetic resonance imaging and correlation with skin fibrosis.

Authors:  Daniel C Lee; Monique E Hinchcliff; Roberto Sarnari; Madeline M Stark; Jungwha Lee; Kimberly Koloms; Aileen Hoffmann; Mary Carns; Anjali Thakrar; Kathleen Aren; John Varga; Alejandro Aquino; James C Carr; Brandon C Benefield; Sanjiv J Shah
Journal:  J Scleroderma Relat Disord       Date:  2018-04-12

10.  Text data extraction for a prospective, research-focused data mart: implementation and validation.

Authors:  Monique Hinchcliff; Eric Just; Sofia Podlusky; John Varga; Rowland W Chang; Warren A Kibbe
Journal:  BMC Med Inform Decis Mak       Date:  2012-09-13       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.